View in EDS

Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971].

Saved in:
Bibliographic Details
Title: Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971].
Authors: Corre E; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Alard A; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Marbœuf C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Lasfargues C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Dailhau S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Gilbert N; IRMB, Université de Montpellier, INSERM, Montpellier, France., Blum Y; Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes), UMR-6290, ERL-U1305, 35000, Rennes, France., Nicolle R; Univ Paris Cité, CNRS, INSERM, CRI (Centre de Recherche sur l'Inflammation), UMR-1149, ERL-8252, 75018, Paris, France., Iovanna J; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France., Dusetti N; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France., Pyronnet S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France. Electronic address: stephane.pyronnet@inserm.fr.
Source: Cancer letters [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218202. Date of Electronic Publication: 2025 Dec 04.
Publication Type: Published Erratum
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2025.218202